-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Synthetic Lethal Metabolic Dependencies in IDH1-Mutant Acute Myeloid Leukemia

Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
Program: Scientific Workshops
Session: Metabolic Mechanisms and Mitochondria Biology Behind Therapy Resistance
Friday, December 8, 2023, 4:14 PM-4:59 PM

Ravi Majeti, MD

Stanford University School of Medicine, Stanford, CA

Disclosures: Majeti: Orbital Therapeutics: Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees; kodikaz Therapeutic Solutions: Membership on an entity's Board of Directors or advisory committees; 858 Therapeutics: Membership on an entity's Board of Directors or advisory committees; Pheast Therapeutics: Current equity holder in private company; MyeloGene: Current equity holder in private company.

See more of: Metabolic Mechanisms and Mitochondria Biology Behind Therapy Resistance
See more of: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation >>